Nonna Shakhnazaryan
Clinical Research Supervisor
HDF Comprehensive Cancer Ctr
School of Medicine

Videos

Show all (1) Hide

• Video (youtube.com)

Publications (9)

Top publication keywords:
Androgen AntagonistsCarcinoma, Renal CellGallium RadioisotopesPatient Education as TopicComprehensionInternetRadiosurgeryProstatic NeoplasmsProstate-Specific AntigenHumansConsumer Health InformationKidney NeoplasmsRetrospective StudiesTreatment OutcomeProspective Studies

• JCO Oncology Practice
  Evaluating an artificial intelligence (AI) communication platform for racial biases in information quality about prostate cancer (PCa) germline testing 2025 Johanna Balas, Lauren Bowling, Nonna Shakhnazaryan, Rahul Raj Aggarwal, Hala Borno, Julian C. Hong, Franklin W. Huang, Barry Tong, Daniel H. Kwon
• Kidney Cancer Research Summit (KCRS25) KidneyCAN
  Molecular Residual Disease (MRD) Guided Adjuvant ThErapy in Renal Cell Carcinoma (RCC) -MRD GATE RCC 2025 Arnab Basu, Fady Sidhom, Caleb Hwang, Nonna Shakhnazaryan, Vishruti Pandya, James Ferguson, Sejong Bae, Soroush Rais-Bahrami, Deepak Kilari, Arpita Desai, Mollie Deshazo, Joelle Hamilton, Charles …
• Journal of Urology
  EVALUATING THE IMPACT OF SOCIAL VULNERABILITY INDEX AND FINANCIAL INFLUENCES ON TREATMENT SELECTION IN PROSTATE CANCER PATIENTS 2025 Nguyen N, Shakhnazaryan N, Wang L, Cowan J, Chan JM, Shariff-Marco S, et al.
• Society of Urologic Oncology
  Intersection Of Individual-Level SES, Community Level Stressors, And Treatment Outcomes For Men With Intermediate And High-Risk Prostate Cancer 2025 Shakhnazaryan N, Jhandi A, Wang L, Cowan JE, Chan J, Shariff-Marco S, Carroll PR, Washington SL
• Accuracy, readability, and quality of websites about metastatic renal cell carcinoma treatment.
  Urologic oncology 2024 Shakhnazaryan N, Gima-Lange L, Desai A, Fitzgerald K, Kwon DH

Show all (4 more) Hide

• Journal of Clinical Oncology
  A phase 1b dose escalation study of FOR46, a novel antibody-drug conjugate targeting a tumor-specific epitope of CD46, in combination with enzalutamide (Enza) in patients with metastatic castration resistant prostate cancer (mCRPC). 2024 Nonna Shakhnazaryan, Nathan Curry, Medini Rastogi, Daniel Avins, Shrina Pandey, Ivan de Kouchkovsky, Daniel Kwon, Arpita Desai, Kelly N. Fitzgerald, Rohit Bose, Jonathan Chou, Terence W. Friedlander, …
• Journal of Clinical Oncology
  Sequential metastasis-directed therapy (MDT) for oligometastatic prostate cancer (Oligo PCa) assessed by PET-based imaging. 2023 Alberto Carretero-González, Daniel Kwon, Nonna Shakhnazaryan, Julian C. Hong, Osama Mohamad, Mary Uan-Sian Feng, Ivan de Kouchkovsky, Hala Borno, Rohit Bose, Jonathan Chou, Arpita Desai, Lawrence Fong…
• Serial stereotactic body radiation therapy for oligometastatic prostate cancer detected by novel PET-based radiotracers.
  Urologic oncology 2022 Kwon DH, Shakhnazaryan N, Shui D, Hong JC, Mohamad O, de Kouchkovsky I, Borno HT, Bose R, Chou J, Desai A, Fong L, Friedlander TW, Koshkin VS, Aggarwal RR, Feng FY, Hope TA, Small EJ
• San Francisco Health Initiative: Creating Agents of Change to Build Capacity for Free Clinic Research.
  Free clinic research collective 2018 Contreras MG, Lee J, Shakhnazaryan N, Shakhnazaryan N, Salamanca N, Creasy K, Tuot D, Marquez-Magaña L